Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

Published:2014-03 Issue: Volume:156 Page:1-7
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

McIntyre Roger S.,Filteau Marie-Josée,Martin Lawrence,Patry Simon,Carvalho Andre,Cha Danielle S.,Barakat Maxime,Miguelez Maia

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference44 articles.

1. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study;Abbasi;J. Affect. Disord.,2012

2. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study;Blier;Am. J. Psychiatr.,2010

3. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study;Carlson;Biol. Psychiatr.,2013

4. Treatment-emergent adverse events associated with atypical antipsychotics;Cha;Expert Opin. Pharmacother.,2012

5. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder;Diazgranados;J. Clin. Psychiatr.,2010

Cited by 348 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT1 Coordinates Transcriptional Regulation of Neural Activity and Modulates Depression-Like Behaviors in the Nucleus Accumbens;Biological Psychiatry;2024-09

2. The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review;Psychedelic Medicine;2024-09-01

3. Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial;Journal of Affective Disorders;2024-09

4. Glutamatergic Modulators for Major Depression from Theory to Clinical Use;CNS Drugs;2024-08-16

5. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment;Journal of Psychopharmacology;2024-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3